AU3201377A - Prostaglandin type compounds - Google Patents

Prostaglandin type compounds

Info

Publication number
AU3201377A
AU3201377A AU32013/77A AU3201377A AU3201377A AU 3201377 A AU3201377 A AU 3201377A AU 32013/77 A AU32013/77 A AU 32013/77A AU 3201377 A AU3201377 A AU 3201377A AU 3201377 A AU3201377 A AU 3201377A
Authority
AU
Australia
Prior art keywords
type compounds
prostaglandin type
prostaglandin
compounds
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32013/77A
Other versions
AU521307B2 (en
Inventor
Waddell Collins And Raphael Pappu Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of AU3201377A publication Critical patent/AU3201377A/en
Application granted granted Critical
Publication of AU521307B2 publication Critical patent/AU521307B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU32013/77A 1976-12-27 1977-12-23 Prostaglandin type compounds Expired AU521307B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75415776A 1976-12-27 1976-12-27
USUS754157 1976-12-27

Publications (2)

Publication Number Publication Date
AU3201377A true AU3201377A (en) 1979-06-28
AU521307B2 AU521307B2 (en) 1982-03-25

Family

ID=25033674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32013/77A Expired AU521307B2 (en) 1976-12-27 1977-12-23 Prostaglandin type compounds

Country Status (17)

Country Link
JP (1) JPS5382759A (en)
AT (1) AT359221B (en)
AU (1) AU521307B2 (en)
BE (1) BE862363A (en)
DE (1) DE2758156A1 (en)
DK (1) DK577277A (en)
FI (1) FI64350C (en)
FR (1) FR2375208A1 (en)
GB (1) GB1553140A (en)
IE (1) IE46358B1 (en)
IL (1) IL53691A (en)
NL (1) NL7714430A (en)
NO (1) NO148333B (en)
NZ (1) NZ186118A (en)
PT (1) PT67456B (en)
SE (1) SE7714765L (en)
ZA (1) ZA777683B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006137472A1 (en) * 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivative

Also Published As

Publication number Publication date
SE7714765L (en) 1978-06-28
FR2375208A1 (en) 1978-07-21
PT67456A (en) 1978-01-01
JPS5382759A (en) 1978-07-21
ATA933777A (en) 1980-03-15
IL53691A0 (en) 1978-03-10
IL53691A (en) 1981-12-31
NO148333B (en) 1983-06-13
GB1553140A (en) 1979-09-19
AU521307B2 (en) 1982-03-25
DK577277A (en) 1978-06-28
NL7714430A (en) 1978-06-29
DE2758156A1 (en) 1978-07-06
NO774465L (en) 1978-06-28
FI773937A (en) 1978-06-28
FR2375208B1 (en) 1980-02-08
FI64350B (en) 1983-07-29
AT359221B (en) 1980-10-27
IE46358B1 (en) 1983-05-18
NZ186118A (en) 1979-11-01
BE862363A (en) 1978-06-27
IE46358L (en) 1978-06-27
PT67456B (en) 1979-05-25
FI64350C (en) 1983-11-10
ZA777683B (en) 1979-08-29

Similar Documents

Publication Publication Date Title
AU502587B2 (en) Prostaglandin analogues
AU509777B2 (en) Polyfluoroallyloxy compounds
NZ183050A (en) Prostaglandin derivatives
AU511408B2 (en) 11-desoxy prostaglandin f2 derivatives
AU506818B2 (en) Prostaglandins
AU520755B2 (en) Polyene compounds
AU504601B2 (en) Prostaglandin derivatives
AU512932B2 (en) 11-deoxy-13, 14-didehydro prostaglandin analogs
AU512931B2 (en) 13, 14-didehydro prostaglandin
AU509274B2 (en) Prostaglandin analogues
AU512953B2 (en) Substituted phenylguanidines
AU521307B2 (en) Prostaglandin type compounds
AU508751B2 (en) Azamethine-cu complex compounds
AU512644B2 (en) Prostaglandin analogues
AU510471B2 (en) Azatetracyclic compounds
AU512595B2 (en) Prostaglandin analogues
AU498923B2 (en) 11-oxy-213 prostaglandin 9-ketals
AU508851B2 (en) Prostaglandin derivatives
AU495400B2 (en) Pyridyltriazinone compounds
AU2569177A (en) Novel substituted chrysanthemates
AU496086B2 (en) Prostaglandin type 1, 15-lactones
AU484287B2 (en) Biphenylyloxy compounds
AU515715B2 (en) Prostacyclin
AU507219B2 (en) Prostaglandin intermediates
AU520892B2 (en) 9-deoxo-9-methylene prostaglandin analogues